Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Four Indian generic companies take sub license from MPP on daclatasvir
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Part 2: How is hepatitis C treated?
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Part 1: What is hepatitis C and how is it diagnosed?
